Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Dec;196(3):453-461.
doi: 10.1007/s10549-022-06754-6. Epub 2022 Oct 8.

Contemporary evaluation of estrogen receptor and progesterone receptor expression in breast cancer-associated stroma

Gustavo A Moreno  1 , Mariel I Molina  1 , Dan Eastwood  2 , Paul L Auer  3 , Julie M Jorns  4
Affiliations

Contemporary evaluation of estrogen receptor and progesterone receptor expression in breast cancer-associated stroma

Gustavo A Moreno et al. Breast Cancer Res Treat. 2022 Dec.

Abstract

Purpose: To investigate nuclear estrogen receptor α (ERα) and progesterone receptor (PR) immunohistochemistry (IHC) patterns in the stroma surrounding invasive carcinoma and assess associations with clinicopathologic features.

Methods: A retrospective database search (1/2017-12/2020) identified breast core biopsies with invasive carcinoma. ERα/PR IHC expression in invasive carcinoma and stromal cells was categorized visually as positive (> 10%), low positive (1-10%) or negative (< 1%). Tumors were divided into 4 subtypes by IHC: Luminal, Luminal HER2, HER2 enriched, and triple negative. Clinicopathologic features associated (univariate p-value < 0.15) with ERα/PR stromal expression were investigated further using stepwise multivariable logistic regression.

Results: Of 1512 biopsies, 1278 had accessible IHC. 55.6% (711/1278) and 10.4% (133/1274) of cases showed cancer-associated stromal fibroblast expression of ERα and PR, respectively. Stromal ER positivity was significantly associated with use of the Ventana (with SP1 clone) versus Leica (with 6F11 clone) platform and in cases with Luminal cancer subtype. PR stromal expression was significantly associated with Luminal subtype, obesity, and younger age.

Conclusions: Expression of ERα and PR in breast cancer-associated stroma showed associations that suggest both biologic and analytic influence. Reproducible expression patterns may inform expansion of ERα/PR guidelines for the assessment of internal controls.

Keywords: Estrogen receptor; Immunohistochemistry; Progesterone receptor; Stromal microenvironment.

PubMed Disclaimer

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249 - DOI - PubMed
    1. Onitilo AA, Engel JM, Greenlee RT, Mukesh BN (2009) Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res 7(1–2):4–13 - DOI - PubMed - PMC
    1. Eliyatkın N, Yalçın E, Zengel B, Aktaş S, Vardar E (2015) Molecular classification of breast carcinoma: from traditional, old-fashioned way to a new age, and a new way. J Breast Health 11(2):59–66 - DOI - PubMed - PMC
    1. Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312(3):146–151 - DOI - PubMed
    1. Neal L, Sandhu NP, Hieken TJ, Glazebrook KN, Mac Bride MB, Dilaveri CA et al (2014) Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy. Mayo Clin Proc 89(4):536–547 - DOI - PubMed

LinkOut - more resources